• Title of article

    Is aversive learning a marker of risk for anxiety disorders in children?

  • Author/Authors

    Michelle G. Craske، نويسنده , , Allison M. Waters، نويسنده , , R. Lindsey Bergman، نويسنده , , Bruce Naliboff، نويسنده , , Ottmar V. Lipp، نويسنده , , Hideki Negoro، نويسنده , , Edward M. Ornitz، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2008
  • Pages
    14
  • From page
    954
  • To page
    967
  • Abstract
    Aversive conditioning and extinction were evaluated in children with anxiety disorders (n=23), at-risk for anxiety disorders (n=15), and controls (n=11). Participants underwent 16 trials of discriminative conditioning of two geometric figures, with (CS+) or without (CS−) an aversive tone (US), followed by 8 extinction trials (4 CS+, 4 CS−), and 8 extinction re-test trials averaging 2 weeks later. Skin conductance responses and verbal ratings of valence and arousal to the CS+/CS− stimuli were measured. Anxiety disordered children showed larger anticipatory and unconditional skin conductance responses across conditioning, and larger orienting and anticipatory skin conductance responses across extinction and extinction re-test, all to the CS+ and CS−, relative to controls. At-risk children showed larger unconditional responses during conditioning, larger orienting responses during the first block of extinction, and larger anticipatory responses during extinction re-test, all to the CS+ and CS−, relative to controls. Also, anxiety disordered children rated the CS+ as more unpleasant than the other groups. Elevated skin conductance responses to signals of threat (CS+) and signals of safety (CS−; CS+ during extinction) are discussed as features of manifestation of and risk for anxiety in children, compared to the specificity of valence judgments to the manifestation of anxiety.
  • Keywords
    ChildrenAnxiety disordersAt-riskConditioningExtinctionSkin conductance
  • Journal title
    Behaviour Research and Therapy
  • Serial Year
    2008
  • Journal title
    Behaviour Research and Therapy
  • Record number

    570404